These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2858082)

  • 1. Can drug effects on anxiety and convulsions be separated?
    Pellow S
    Neurosci Biobehav Rev; 1985; 9(1):55-73. PubMed ID: 2858082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GABA-A receptor complex and memory processes.
    Chapouthier G; Venault P
    Curr Top Med Chem; 2002 Aug; 2(8):841-51. PubMed ID: 12171575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.
    Pellow S; File SE
    Pharmacol Biochem Behav; 1986 Mar; 24(3):525-9. PubMed ID: 2871560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is tofisopam an atypical anxiolytic?
    Pellow S; File SE
    Neurosci Biobehav Rev; 1986; 10(2):221-7. PubMed ID: 2874535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The relationship between anticonvulsant and anti-anxiety effects of calcium channel blockers].
    Kozlovskiĭ VL
    Eksp Klin Farmakol; 1997; 60(5):19-22. PubMed ID: 9483399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substantia nigra GABA receptors can mediate anticonvulsant or proconvulsant effects.
    Moshé SL; Garant DS
    Epilepsy Res Suppl; 1996; 12():247-56. PubMed ID: 9302523
    [No Abstract]   [Full Text] [Related]  

  • 7. Azirino[1, 2-d][1, 4]benzodiazepine derivatives and related 1,4-benzodiazepines as anticonvulsant agents in DBA/2 mice.
    De Sarro G; Chimirri A; Zappala M; Guisti P; Lipartiti M; De Sarro A
    Gen Pharmacol; 1996 Oct; 27(7):1155-62. PubMed ID: 8981061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A search for a new anticonvulsant and anxiolytic benzodiazepine devoid of side effects and tolerance liability.
    Costa E; Auta J; Caruncho H; Guidotti A; Impagnatiello F; Pesold C; Thompson DM
    Adv Biochem Psychopharmacol; 1995; 48():75-92. PubMed ID: 7653327
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence for the pharmacological relevance of benzodiazepine receptors to anticonvulsant activity.
    Fisher TE; Johnson DD; Tuchek JM; Crawford RD
    Can J Physiol Pharmacol; 1985 Nov; 63(11):1477-9. PubMed ID: 2866832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pro- and anti-convulsant drug effects in combination with the convulsant benzodiazepine Ro 5-4864.
    Pellow S; File SE
    J Pharm Pharmacol; 1985 Aug; 37(8):560-3. PubMed ID: 2864417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticonvulsant activity of azirino[1,2-d][1,4]benzodiazepines and related 1,4-benzodiazepines in mice.
    De Sarro G; Chimirri A; McKernan R; Quirk K; Giusti P; De Sarro A
    Pharmacol Biochem Behav; 1997 Sep; 58(1):281-9. PubMed ID: 9264104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative anticonvulsant effects of GABAmimetic and GABA modulatory agents.
    Holland KD; McKeon AC; Canney DJ; Covey DF; Ferrendelli JA
    Epilepsia; 1992; 33(6):981-6. PubMed ID: 1334454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticonvulsant, anxiolytic, and non-sedating actions of imidazenil and other imidazo-benzodiazepine carboxamide derivatives.
    Auta J; Kadriu B; Giusti P; Costa E; Guidotti A
    Pharmacol Biochem Behav; 2010 Jun; 95(4):383-9. PubMed ID: 20227434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convulsions induced by centrally administered NMDA in mice: effects of NMDA antagonists, benzodiazepines, minor tranquilizers and anticonvulsants.
    Moreau JL; Pieri L; Prud'hon B
    Br J Pharmacol; 1989 Nov; 98(3):1050-4. PubMed ID: 2574061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticonvulsant and anxiolytic-like effects of compounds isolated from Polygala sabulosa (Polygalaceae) in rodents: in vitro and in vivo interactions with benzodiazepine binding sites.
    Duarte FS; Marder M; Hoeller AA; Duzzioni M; Mendes BG; Pizzolatti MG; De Lima TC
    Psychopharmacology (Berl); 2008 Apr; 197(3):351-60. PubMed ID: 18157522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential pharmacological effects of benzodiazepine receptor inverse agonists.
    Petersen EN; Jensen LH; Honoré T; Braestrup C
    Adv Biochem Psychopharmacol; 1983; 38():57-64. PubMed ID: 6142608
    [No Abstract]   [Full Text] [Related]  

  • 17. Anxiety, anxiolytics and brain stimulation reinforcement.
    Liebman JM
    Neurosci Biobehav Rev; 1985; 9(1):75-86. PubMed ID: 2858083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The neurotransmitter inhibitor GABA, the basis of the mechanism of action of several drugs affecting the central nervous system].
    Rodríguez-Trelles FA
    An R Acad Nac Med (Madr); 1984; 101(4):431-52. PubMed ID: 6152518
    [No Abstract]   [Full Text] [Related]  

  • 19. Decreased sensitivity to diazepam induced by chronic administration of FG 7142.
    Corda MG; Giorgi O; Longoni B; Biggio G
    Neurosci Lett; 1988 Mar; 86(2):219-24. PubMed ID: 2835714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted deletion of the GABRA2 gene encoding alpha2-subunits of GABA(A) receptors facilitates performance of a conditioned emotional response, and abolishes anxiolytic effects of benzodiazepines and barbiturates.
    Dixon CI; Rosahl TW; Stephens DN
    Pharmacol Biochem Behav; 2008 Jul; 90(1):1-8. PubMed ID: 18313124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.